Publications

Papers

2022

  1. Nazari-Farsani S., Yu Y., Armindo R.D., Lansberg M., Liebeskind D.S., Albers G., Christensen S., Levin C.S., Zaharchuk G. Predicting final ischemic stroke lesions from initial diffusion-weighted images using a deep neural network. NeuroImage: Clinical. 2022 December; 37: 103278. doi: 10.1016/j.nicl.2022.103278.
  2. Yu Y., Christensen S., Ouyang J., Scalzo F., Leibeskind D.S., Lansberg M.G., Albers G.W., Zaharchuk G. Predicting Hypoperfusion Lesion and Target Mismatch in Stroke from Diffusion-weighted MRI Using Deep Learning. Radiology. 2022 December; 220882. doi: 10.1148/radiol.220882.
  3. Zhao M.Y., Armindo R.D., Gauden A.J., Yim B., Tong E., Moseley M.E., Steinberg G.K., Zaharchuk G. Revascularization improves vascular hemodynamics - a study assessing cerebrovascular reserve and transit time in Moyamoya patients using MRI. Journal of Cerebral Blood Flow & Metabolism. 2022 November: 271678X221140343. doi: 10.1177/0271678X221140343.
  4. Roytman M., Mashriqi F., Al-Tawil K., Schulz P.E., Zaharchuk G., Benzinger T.L.S. Franceschi A.M. Amyloid-Related Imaging Abnormalities: An Update. American Journal of Roentgenology. 2022 November. doi: 10.2214/AJR.22.28461.
  5. Zhao M.Y., Fan A.P., Chen D.Y., Ishii Y., Khalighi M.M., Moseley M.E., Steinberg G.K., Zaharchuk G. Using arterial spin labeling to measure cerebrovascular reactivity in Moyamoya disease: Insights from simulataneous PET/MRI. Journal of Cerebral Blood Flow & Metabolism. 2022 August; 42(8): 1493-1506. doi: 10.1177/0271678X221083471.
  6. Zhao M.Y., Woodward A., Fan A.P., Chen K.T., Yu Y., Chen D.Y., Moseley M.E., Zaharchuk G. Reproducibility of cerebrovascular reactivity measurements: A systematic review of neuroimaging techniques. Journal of Cerebral Blood Flow & Metabolism. 2022 May; 42(5): 700-717. doi: 10.1177/0271678X211056702.
  7. Chen K.T., Adeyeri O., Toueg T.N., Zeineh M., Mormino E., Khalighi M., Zaharchuk G. Investigating Simultaneity for Deep Learning-Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging. American Journal of Neuroradiology. 2022 March; 43(3): 354-360. doi: 10.3174/ajnr.A7410.
  8. Kiru, L., Zlitni A., Tousley A.M., Dalton G.N., Wu W., Lafortune F., Liu A., Cunanan K.M., Nejadnik H., Sulchek T., Moseley M.E., Majzner R.G., Daldrup-Link H.E. In vivo imaging of nanoparticle-labeled CAR T cells. Proceedings of the National Academy of Sciences of the United States of America. 2022 January; 119(6): e2102363119. doi: 10.1073/pnas.2102363119.

2021

  1. Ouyang J., Zhao Q., Adeli E., Sullivan E.V., Pfefferbaum A., Zaharchuk G., Pohl K.M. Self-supervised Longitudinal Neighbourhood Embedding. Medical Image Computing and Computer Assisted Intervention. 2021 September; 12902: 80-89. doi: 10.1007/978-3-030-87196-3_8.
  2. Ouyang J., Adeli E., Pohl K.M., Zhao Q., Zaharchuk G. Representation Disentanglement for Multi-modal Brain MRI Analysis. Information Processing in Medical Imaging. 2021 June; 12729: 321-333. doi: 10.1007/978-3-030-78191-0_25.
  3. Zhao M.Y., Fan A.P., Chen D.Y., Sokolska M.J., Guo J., Ishii Y., Shin D.D., Khalighi M.M., Holley D., Halbert K., Otte A., Williams B., Rostami T., Park J.H., Shen B., Zaharchuk, G. Cerebrovascular reactivity measurements using simultaneous 15O-water PET and ASL MRI: Impacts of arterial transit time, labeling efficiency, and hematocrit. NeuroImage. 2021 June; 233: 117955. doi: 10.1016/j.neuroimage.2021.117955.
  4. Zhou, Q., Vega Leonel J.C.M., Santoso M.R., Wilson C., Van Den Berg N.S., Chan C.T., Aryal M., Vogel H., Cayrol R., Mandella M.J., Schonig F., Lu G., Gambhir S.S., Moseley M.E., Rosenthal E.L., Grant G.A. Molecular imaging of a flourescent antibody against epidermal growth factor receptor detects high-grade glioma. Scientific Reports. 2021 March; 11(1): 5710. doi: 10.1038/s41598-021-84831-4.
  5. Lanzman B.A., Huang Y., Lee E.H., Iv M., Moseley M.E., Holdsworth S.J., Yeom K.W. Simultaneous time of flight-MRA and T2* imaging for cerebrovascular MRI. Paediatric Neuroradiology. 2021 February: 63(2): 243-251. doi: 10.1007/s00234-020-02499-5.

2020

  1. Iv M., Ng N.N., Nair S., Zhang, Y., Lavezo, J., Cheshier S.H., Holdsworth S.J., Moseley M.E., Rosenberg J., Grant G.A., Yeom K.W. Brain Iron Assessment after Feurmoxytol-ehanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study. Radiology. 2020 November; 297(2): 438-446. doi: 10.1148/radiol.2020200378.
  2. Soman S., Dai W., Dong L., Hitchner E., Lee K., Baughman B.D., Holdsworth S.J., Massaband P., Bhat J.V., Moseley M.E., Rosen A., Zhou W., Zaharchuk G. Identifying cardiovascular risk factors that impact cerebrovascular reactivity: An ASL MRI study. Journal of Magnetic Resonance Imaging. 2020 March; 51(3): 734-747. doi: 10.1002/jmri.26862.

2018

  1. Jahanian H., Christen T., Moseley M.E., Zaharchuk G. Erroneous Resting-State fMRI Connectivity Maps Due to Prolonged Arterial Arrival Time and How to Fix Them. Brain Connect. 2018 August; 8(6): 362-370. doi: 10.1089/brain.2018.0610.
  2. Santoro J.D., Forkert N.D., Yang Q.Z., Pavitt S., MacEachern S.J., Moseley M.E., Yeom, K.W. Brain Diffusion Abnormalities in Children with Tension-Type and Migrane-Type Headaches.  American Journal of Neuroradiology. 2018 May; 39(5): 935-941. doi: 10.3174/ajnr.A5582.

2017

  1. Jahanian H., Christen T., Moseley M.E., Pajewski N.M., Wright C.B., Tamura M.K., Zaharchuk, G. Measuring vascular reactivity with resting-state blood oxygenation level-dependent (BOLD) signal fluctuations: A potential alternative to the breath-holding challenge? Journal of Cerebral Blood Flow & Metabolism. 2017 July; 37(7): 2526-2538. doi: 10.1177/0271678X16670921.
  2. Ni W.W., Christen T., Rosenberg J., Zun Z., Moseley M.E., Zaharchuk G. Imaging of cerebrovascular reserve and oxygenation in Moyamoya disease. Journal of Cerebral Blood Flow & Metabolism. 2017 April; 37(4): 1213-1222. doi: 10.1177/0271678X16651088.

2016

  1. Soman S., Prasad G., Hitchner E., Massaband P., Moseley M.E., Zhou W., Rosen A.C. Brain structural connectivity distinguishes patients at risk for cognitive decline after carotid interventions.  Human Brain Mapping. 2016 June; 37(6): 2185-2194. doi: 10.1002/hbm.23166.
  2. Amukotuwa S.A., Yu C., Zaharchuk G. 3D Pseudocontinuous aterial spin labeling in routine clinical practice: A review of clinically significant artifacts. Journal of Magnetic Resonance Imaging. 2016 January; 43(1): 11-27. doi: 10.1002/jmri.24873.

2015

  1. Iagaru A., Mosci C., Mittra E., Zaharchuk G., Fischbein N., Harsh G., Li G., Nagpal S., Recht L., Gambhir S.S. Glioblastoma Multiforme Recurrence: An Exploratory Study of 18F FPPRGD2 PET/CT. Radiology. 2015 November; 277(2): 497-506. doi: 10.1148/radiol.2015141550.
  2. Kleinman J.T., Mlynash M., Zaharchuk G., Ogdie A.A., Straka M., Lansberg M.G., Schwartz N.E., Singh P., Kemp S., Bammer R., Albers G.W., Olivot JM. Yield of CT perfusion for the evaluation of transient ischaemic attack. International Journal of Stroke. 2015 October; 10(SA100): 25-29. doi: 10.1111/j.1747-4949.2012.00941.x.
  3. Wheeler H.M., Mlynash M., Inoue M., Tipirnini A., Liggins J., Bammer R., Lansberg M.G., Kemp S., Zaharchuk G., Straka M., Albers G.W. The growth rate of early DWI lesions is highly variable and associated with penumbral salvage and clinical outcomes following endovascular reperfusion. International Journal of Stroke. 2015 July; 10(5): 723-729. doi: 10.1111/ijs.12436.
  4. Yeom K.W., Straka M., Iv M., Moseley M.E., Barnes P.D., Skare S., Holdsworth S.J. Intensity-Corrected Dual-Echo Echo-Planar Imaging (DE-EPI) for Improved Pediatric Brain Diffusion Imaging. PLoS ONE. 2015 June; 10(6): e0129325. doi: 10.1371/journal.pone.0129325.
  5. Zun Z., Hargreaves B.A., Rosenberg J., Zaharchuk G. Improved multislice perfusion imaging with velocity-selective arterial spin labeling. Journal of Magnetic Resonance Imaging. 2015 May; 41(5): 1422-1431. doi: 10.1002/jmri.24652.
  6. Holdsworth S.J., Yeom K.W., Moseley M.E., Skare S. Fast susceptibility-weighted imaging with three-dimensional short-axis propeller (SAP)-echo-planar imaging. Journal of Magnetic Resonance Imaging. 2015 May; 41(5): 1447-1453. doi: 10.1002/jmri.24675.
  7.  Andre J.B., Nagpal S., Hippe D.S., Ravanpay A.C., Schmiedeskamp H., Bammer R., Palagallo G.J., Recht L., Zaharchuk G. Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain. The Neuroradiology Journal. 2015 April; 28(2): 112-119. doi: 10.1177/1971400915576641.
  8. Vora N., Tung C.E., Mlynash M., Garcia M., Kemp S., Kleinman J., Zaharchuk G., Albers G., Olivot J.M. TIA Triage in Emergency Department Using Acute MRI (TIA-TEAM): A Feasibility and Safety Study. International Journal of Stroke. 2015 April; 10(3): 343-347. doi: 10.1111/ijs.12390.
  9. Iv M., Telischak N., Feng D., Holdsworth S.J., Yeom K.W., Daldrup-Link H.E. Clinical applications of iron oxide nanoparticles for magnetic resonance imaging of brian tumors. Nanomedicine. 2015 March; 10(6): 993-1018. doi: 10.2217/nnm.14.203.
  10. Soman S., Holdsworth S.J., Skare S., Andre J.B., Van A.T., Aksoy M., Bammer R., Rosenberg J., Barnes P.D., Yeom K.W. Effect of Number of Acquisitions in Diffusion Tensor Imaging of the Pediatric Brain: Optimizing Scan Time and Diagnosic Experience. Journal of Neuroimaging. 2015 March; 25(2): 296-302. doi: 10.1111/jon.12093.
  11. Ni W.W., Christen T., Zun Z., Zaharchuk G. Comparison of R2' measurement methods in the normal brain at 3 Tesla. Magnetic Resonance in Medicine. 2015 March; 73(3): 1228-1236. doi: 10.1002/mrm.25232.
  12. Christen T., Jahanian H., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Noncontrast mapping of arterial delay and functional connectivity using resting-state functional MRI: A study in Moyamoya patients. Journal of Magnetic Resonance Imaging. 2015 February; 41(2): 424-430. doi: 10.1002/jmri.24558.
  13. Iagaru A., Mittra E., Minamimoto R., Jamali M., Levin C., Quon A., Gold G., Herfkens R., Vasanawala S., Gambhir S.S., Zaharchuk G. Simultaneous Whole-Body Time-of-Flight 18F-FDG PET/MRI: A Pilot Study Comparing SUVmax with PET/CT and Assessment of MR Image Quality. Clinical Nuclear Medicine. 2015 January; 40(1): 1-8. doi: 10.1097/RLU.0000000000000611.

2014

  1. Zun Z., Shankaranarayanan A., Zaharchuk G. Pseudocontinuous arterial spin labeling with prospective motion correction (PCASL-PROMO). Magnetic Resonance in Medicine. October 2014; 72(4): 1049-1056. doi: 10.1002/mrm.25024.
  2. Pannetier N.A., Sohlin M., Christen T., Schad L.R., Schuff N. Numerical modeling of susceptibility-related MR signal dephasing with vessel size measurement: Phantom validation at 3T. Magnetic Resonance in Medicine. 2014 September; 72(3): 646-658. doi: 10.1002/mrm.24968.
  3. Christen T., Bouzat P., Pannetier N., Coquery N., Moisan A., Lemasson B., Thomas S., Grillon E., Detante O., Remy C., Payen JF., Barbier E.L. Tissue Oxygen Saturation Mapping with Magnetic Resonance Imaging. Journal of Cerebral Blood Flow & Metabolism. 2014 September; 34(9): 1550-1557. doi: 10.1038/jcbfm.2014.116.
  4. Holdsworth S.J., Yeom K.W., Antonucci M.U., Andre J.B., Rosenberg J., Aksoy M., Straka M., Fischbein N.J., Bammer R., Moseley M.E., Zaharchuk G., Skare S. Diffusion-Weighted Imaging with Dual-Echo Echo-Planar Imaging for Better Sensitivty to Acute Stroke. American Journal of Neuroradiology. 2014 July; 35(7): 1293-1302. doi: 10.3174/ajnr.A3921.
  5. Zun Z., Hargreaves B.A., Pauly J., Zaharchuk G. Near-contiguous spin echo imaging using matched-phase RF and its application in velocity-selective arterial spin labeling. Magnetic Resonance in Medicine. 2014 June; 71(6): 2043-2050. doi: 10.1002/mrm.24866.
  6. Christen T., Pannetier N.A., Ni W.W., Qiu D., Moseley M.E., Schuff N., Zaharchuk G. MR vascular fingerprinting: A new approach to compute blood volume, mean vessel radius and blood oxygenation maps in the human brain. NeuroImage. 2014 April; 89: 262-270. doi: 10.1016/j.neuroimage.2013.11.052.
  7. Inoue M., Mlynash M., Christensen S., Wheeler H.M., Straka M., Tipirneni A., Kemp S.M., Zaharchuk G., Olivot JM., Bammer R., Lansberg M.G., Albers G.W. Early Diffusion-Weighted Imaging Reversal After Endovascular Reperfusion Is Typically Transient in Patients Imaged 3 to 6 Hours After Onset. STROKE. 2014 April; 45(4): 1024-1028. doi: 10.1161/STROKEAHA.113.002135.
  8. Marks M.P., Lansberg M.G., Mlynash M., Olivot JM., Straka M., Kemp S.M., McTaggart R., Inoue M., Zaharchuk G., Bammer R., Albers G.W. Effect of Collateral Blood Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke. STROKE. 2014 April; 45(4): 1035-1039. doi: 10.1161/STROKEAHA.113.004085.
  9. Olivot J.M., Mlynash M., Inoue M., Marks M.P., Wheeler H.M., Kemp S., Straka M., Zaharchuk G., Bammer R., Lansberg M.G., Albers G.W. Hypoperfusion Intensity Ratio Predicts Infarct Progression and Functional Outcome in DEFUSE 2 Cohort. STROKE. 2014 April; 45(4): 1018-1023. doi: 10.1161/STROKEAHA.113.003857.
  10. Jahanian H., Ni W.W., Christen T., Moseley M.E., Tamura M.K., Zaharchuk G. Spontaneous BOLD Fluctuations in Young Healthy Subjects and Elderly Patients with Chronic Kidney Disease. PLoS One. 2014 March; 9(3): e92539. doi: 10.1371/journal.pone.0092539.

2013

  1. D'Arceuil H., Coimbra A., Triano P., Dougherty M., Mello J., Moseley M.E., Glover G., Lansberg M., Blankenberg F. Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain. NeuroImage. 2013 December; 83: 200-209. doi: 10.1016/j.neuroimage.2013.06.066.
  2. Wintermark M., Sanelli P.C., Albers G.W., Bello J.A., Derdeyn C.P., Hetts S.W., Johnson M.H., Kidwell C.S., Lev M.H., Liebeskind D.S., Rowley H.A., Schaefer P.W., Sunshine J.L., Zaharchuk G., Meltzer C.C. Imaging Reccomendations for Acute Stroke and Transient Ischemic Attack Patients: A Joint Statement by the American Society of Neuroradiology, the American College of Radiology and the Society of NeuroInterventional Surgery. Journal of the American College of Radiology. 2013 November; 10(11): 828-832. doi: 10.1016/j.jacr.2013.06.019.
  3. Christen T., Ni W.W., Qiu D., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol. Magnetic Resonance in Medicine. 2013 September; 70(3): 705-710. doi: 10.1002/mrm.24500.
  4. Bouchet A., Lemasson B., Christen T., Potez M., Rome C., Coquery N., Le Clec'h C., Moisan A., Brauer-Krisch E., Leduc G., Remy C., Laissue J.A., Barbier E.L., Brun E., Serduc R. Synchrotron microbeam radiation therapy induces hypoxia in intracerebral gliosarcoma but not in the normal brain. Radiotherapy and Oncology. 2013 July; 108(1): 143-148. doi: 10.1016/j.radonc.2013.05.013.
  5. Christen T., Bolar D.S., Zaharchuk G. Imaging Brain Oxygenation with MRI Using Blood Oxygenation Approaches: Methods, Validation, and Clinical Applications. American Journal of Neuroradiology. 2013 June; 34(6): 1113-1123. doi: 10.3174/ajnr.A3070.
  6. Schmiedeskamp H., Andre J.B., Straka M., Christen T., Nagpal S., Recht L., Thomas R.P., Zaharchuk G., Bammer R. Simultaneous Perfusion and Permeability Measurements Using Combined Spin- and Gradient-Echo MRI. Journal of Cerebral Blood Flow & Metabolism. 2013 May; 33(5): 732-743. doi: 10.1038/jcbfm.2013.10.
  7. Wheeler H.M., Mlynash M., Inoue M., Tipirneni A., Liggins J., Zaharchuk G., Straka M., Kemp S., Bammer R., Lansberg M.G., Albers G.W. Early Diffusion-Weighted Imaging and Perfusion-Weighted Imaging Lesion Volumes Forecast Final Infarct Size in DEFUSE 2. STROKE. 2013 March; 44(3): 681-685. doi: 10.1161/STROKEAHA.111.000135.
  8. Pannetier N.A., Debacker C.S., Mauconduit F., Christen T., Barbier E.L. A Simulation Tool for Dynamic Contrast Enhanced MRI. PLoS One. 2013 March; 8(3): e57636. doi: 10.1371/journal.pone.0057636.

2012

  1. Lemasson B., Christen T., Serduc R., Maisin C., Bouchet A., Le Duc G., Remy C., Barbier E.L. Evaluation of the Relationship between MR Estimates of Blood Oxygen Saturation and Hypoxia: Effect of an Antiangiogenic Treatment on a Gliosarcoma Model. Radiology. 2012 December; 265(3): 743-752. doi: 10.1148/radiol.12112621.
  2. Andre J.B., Zaharchuk G., Saritas E., Komakula S., Shankaranarayan A., Banerjee S., Rosenberg J., Nishimura D.G., Fischbein N.J. Clinical Evaluation of Reduced Field-of-View Diffusion-Weighted Imaging of the Cervical and Thoracic Spine and Spinal Cord. American Journal of Neuroradiology. 2012 November; 33(10): 1860-1866. doi: 10.3174/ajnr.A3134.
  3. Lansberg M.G., Straka M., Kemp S., Mlynash M., Wechsler L.R., Jovin T.G., Wilder M.J., Lutsep H.L., Czartoski T.J., Bernstein R.A., Chang C.WJ., Warach S., Fazekas F., Inoue M., Tipirneni A., Hamilton S.A., Zaharchuk G., Marks M.P., Bammer R., Albers G.W. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): A prospective cohort study. The Lancet Neurology. 2012 October; 11(10): 860-867. doi: 10.1016/S1474-4422(12)70203-X.
  4. Zaharchuk G., Olivot JM., Fischbein N.J., Bammer R., Straka M., Kleinman J.T., Albers G.W. Arterial Spin Labeling Imaging Findings in Transient Ischemic Attack Patients: Comparison with Diffusion- and Bolus Perfusion-Weighted Imaging. Cerebrovascular Diseases. 2012 September; 34(3): 221-228. doi: 10.1159/000339682.
  5. McTaggart R.A., Fischbein N.J., Elkins C.J., Hsiao A., Cutalo M.J., Rosenberg J., Dake M.D., Zaharchuk G. Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls. American Journal of Neuroradiology. 2012 September; 33(8): 1615-1620. doi: 10.3174/ajnr.A3097.
  6. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Contrast-enhanced functional blood volume imaging (CE-fBVI): Enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol. NeuroImage. 2012 September; 62(3): 1726-1731. doi: 10.1016/j.neuroimage.2012.05.010.
  7. Christen T., Schmiedeskamp H., Straka M., Bammer R., Zaharchuk G. Measuring brain oxygenation in humans using a multiparametric quantitative blood oxygenation level dependent MRI approach. Magnetic Resonance in Medicine. 2012 September; 68(3): 905-911. doi: 10.1002/mrm.23283.
  8. Inoue M., Mlynash M., Straka M., Lansberg M.G., Zaharchuk G., Bammer R., Albers G.W. Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy. STROKE. 2012 September; 43(9): 2494-2496. doi: 10.1161/STROKEAHA.112.653329.
  9. Andre J.B., Zaharchuk G., Fischbein N.J., Augustin M., Skare S., Straka M., Rosenberg J., Lansberg M.G., Kemp S., Wijman C.A., Albers G.W., Schwartz N.E., Bammer R. Clinical Assessment of Standard and Generalized Autocalibrating Partially Parallel Acquisition Diffusion Imaging: Effects of Reduction Factor and Spatial Resolution. American Journal of Neuroradiology. 2012 August; 33(7): 1337-1342. doi: 10.3174/ajnr.A2980.
  10. Schmiedeskamp H., Straka M., Newbould R.D., Zaharchuk G., Andre J.B., Olivot JM., Moseley M.E., Albers G.W., Bammer R. Combined spin- and gradient-echo perfusion-weighted imaging. Magnetic Resonance in Medicine. 2012 July; 68(1): 30-40. doi: 10.1002/mrm.23195.
  11. Qiu D., Straka M., Zun Z., Bammer R., Moseley M.E., Zaharchuk G. CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: Comparison with xenon CT CBF. Journal of Magnetic Resonance Imaging. 2012 July; 36(1): 110-119. doi: 10.1002/jmri.23613.
  12. Zaharchuk G. Arterial Spin Labeling for Acute Stroke: Practical Considerations. Translational Stroke Research. 2012 June; 3(2): 228-235. doi: 10.1007/s12975-012-0159-8.
  13. Ghanouni P., Behera D., Xie J., Chen X., Moseley M.E., Biswal S. In vivo USPIO Magnetic Resonance Imaging Shows That Minocycline Mitigates Macrophage Recruitment to a Peripheral Nerve Injury. Molecular Pain. 2012 June; 8: 49. doi: 10.1186/1744-8069-8-49.
  14. Kleinman J.T., Zaharchuk G., Mlynash M., Ogdie A.A., Straka M., Lansberg M.G., Schwartz N.E., Kemp S., Bammer R., Albers G.W., Olivot JM. Automated Perfusion Imaging for the Evaluation of Transient Ischemic Attack. STROKE. 2012 June; 43(6): 1556-1560. doi: 10.1161/STROKEAHA.111.644971.
  15. Christen T., Zaharchuk G., Pannetier N., Serduc R., Joudiou N., Vial JC. Remy C., Barbier E.L. Quantitative MR estimates of blood oxygenation based on T2*: A numerical study of the impact of model assumptions. Magnetic Resonance in Medicine. 2012 May; 67(5): 1458-1468. doi: 10.1002/mrm.23094.
  16. Zaharchuk G. Better Late than Never: The Long Journey for Noncontrast Arterial Spin Labeling Perfusion Imaging in Acute Stroke. STROKE. 2012 April; 43(4): 931-932. doi: 10.1161/STROKEAHA.111.644344.
  17. Jacobs K.E., Behera D., Rosenberg J., Gold G., Moseley M.E., Yeomans D., Biswal S. Oral manganese as an MRI contrast agent for the detection of nociceptive activity. NMR in Biomedicine. 2012 April; 25(4): 563-569. doi: 10.1002/nbm.1773.
  18. Christen T., Lemasson B., Pannetier N., Farion R., Remy C., Zaharchuk G., Barbier E.L. Is T2* Enough to Assess Oxygenation? Quantitative Blood Oxygen Level-Dependent Analysis in Brain Tumor. Radiology. 2012 February; 262(2): 495-502. doi: 10.1148/radiol.11110518.
  19. Wang C., Stebbins G.T., Medina D.A., Shah R.C., Bammer R., Moseley M.E., deToledo-Morrell L. Atrophy and dysfunction of parahippocampal white matter in mild Alzheimer's disease. Neurobiology of Aging. 2012 January; 33(1): 43-52. doi: 10.1016/j.neurobiolaging.2010.01.020.

Proceedings

2014

  1. Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Moseley M.E., Zaharchuk G. Advanced Analysis of USPIO Injection in Normal Volunteers. ISMRM, Milan (Poster). Summa Cum Laude Award.
  2. Christen T., Jahanian H., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Imaging the ‘Dis-Connectome’: Using Resting-State fMRI to Study Perfusion and Connectivity Deficits in Patients with Cerebrovascular Disease. ISMRM, Milan (Poster). Magna Cum Laude Award.
  3. Christen T., Jahanian H., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Non-Contrast Mapping of Arterial Delay and Functional Connectivity Using Resting-State Functional MRI: A Study in Moyamoya Patients. ISMRM, Milan (Oral). Young Investigator Award Presentation.
  4. Lemasson B., Pannetier N., Farion R., Barbier E., Schuff N., Moseley M.E., Zaharchuk G., Christen T. Vascular Fingerprinting in Rat Brain Tumor. ISMRM, Milan (Oral).
  5. Pannetier N., Christen T., Schuff N. Effects of Realistic Vascular Networks Anisotropy on MR Microvascular Imaging. ISMRM, Milan (Oral). Magna Cum Laude Award.
  6. Soman S., Prasad G., Hitchner E., Wei Z., Moseley M.E., Rosen A. Using Structural Connectivity Graph Analysis to Predict Cognitive Decline in Patients After Carotid Endarterectomy. ISMRM, Milan (Oral). Summa Cum Laude Award
  7. Jahanian H., Christen T., Moseley M.E., Zaharchuk G. Accounting for Arterial Transit Delays Is Crucial for Identifying Functional Connectivity Networks: A Resting-State fMRI Study of the Default Mode Network in Moyamoya Disease Patients. ISMRM, Milan (Power Poster).
  8. Jahanian H., Ni W.W., Christen T., Moseley M.E., Tamura M.K., Zaharchuk G. Assessing Vascular Reactivity with Resting-State BOLD Signal Fluctuations: A Clinically Practical Alternative to the Breath-Hold Challenge. ISMRM, Milan (Poster).
  9. Ni W.W., Vriens D., de Geus-Oei L.F., Oyen W., Bengtsson T., de Crespigny A., Sanabria S. Significant impact of FDG plasma kinetics and uptake time on tumor SUV in oncology clinical trials. Proc. Soc. Nuc. Med. Mol. Im. 2014.
  10. Ni W.W., Chang C., Jahanian H., Glover G.H., Zaharchuk G. Impact of Hypertension and Aging on Restin State BOLD Response to Heart Rate Variation. ISMRM, Milan (Poster).
  11. Ni W.W., Chang C., Jahanian H., Glover G.H., Zaharchuk G. Aging-Related Reduction in Physiological Signal Contribution to Resting State fMRI. ISMRM, Milan (Poster).
  12. Holdsworth S.J., Skare S., Yeom K.W., Moseley M.E. Faster Pediatric Brain MRI. ISMRM, Milan, (Poster).
  13. Holdsworth S.J., Skare S.,Yeom K.W., Moseley M.E. Fluid attenuated inversion recovery (FLAIR) with readout-segmented (rs)-EPI. ISMRM, Milan (Oral).
  14. Park J.M., Khalighi M.M., Qiu D., Zaharchuk G., Liu C., Moseley M.E. Considerations in p-space susceptibility tensor imaging: k-space truncation effect, T2* dependence, and 3T/7T comparison. ISMRM, Milan (Poster).
  15. Zun Z., Lebel R.M., Qiu D., Shankaranarayanan A., Zaharchuk G. Comparison of CBF Augmentation with Diamox Challenge Using Arterial Spin Labeling and Xenon CT in Moyamoya Disease. ISMRM, Milan (Poster).
  16. Aksoy M., Maclaren J., Ooi M., Ehrl J., Aksoy D., Zun Z., Bammer R. Prospective Optical Motion Correction for 3D Pseudo-Continuous Arterial Spin Labelling. ISMRM, Milan (Oral).
  17. Zun Z., Lebel R.M., Qiu D., Shankaranarayanan A., Zaharchuk G. What Is the Ideal Labeling Duration for Pseudocontinuous Arterial Spin Labeling? ISMRM, Milan (Poster).
  18. Schmiedeskamp H., Peterson E., Maclaren J., O’Halloran R., Christen T., Holdsworth S., Aboussouan E., Grissom W., Bammer R. Multiband Spin- And Gradient-Echo (SAGE) fMRI.ISMRM, Milan (Poster).
  19. Lemasson B., Pannetier N., Christen T., Zaharchuk G., Schuff N., Barbier E. Mapping Blood Volume Fraction and Vessel Size Index at Steady-State: Impact of Contrast Agent Dose and Spin-Echo Time. ISMRM, Milan (Poster).
  20. Christen T., Pannetier N., Ni W.W., Qiu, D., Schuff N., Moseley M.E., Zaharchuk G. MR Vascular Fingerprinting. CBIS, Stanford (Oral).

2013

  1. Zun Z., Shankaranarayanan A., Zaharchuk G. Comparing 3D Velocity-Selective Arterial Spin Labeling to 3D Pseudocontinuous Arterial Spin Labeling. ISMRM, Salt Lake City (Poster)
  2. Zun Z., Qiu D., Rosenberg J., Zaharchuk G. Longitudinal Study of Cerebral Blood Flow Measurements in Normals Using Pseudocontinuous and Velocity-Selective Arterial Spin Labeling. ISMRM, Salt Lake City (Poster)
  3. Zun Z., Shankaranarayanan A., Zaharchuk G. Pseudocontinuous Arterial Spin Labeling with Prospective Motion Correction (PCASL-PROMO). ISMRM, Salt Lake City (Poster)
  4. Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. Combined Spin and Gradient Echo Imaging Following Injection of USPIOs in Humans.ISMRM, Salt Lake City (Oral). Magna Cum Laude Award.
  5. Christen T., Pannetier N., Ni W.W., Qiu D., Schuff N., Moseley M.E., Zaharchuk G. A Fingerprinting Approach to Compute Blood Volume, Vessel Diameter and Blood Oxygenation Maps in the Human Brain. ISMRM, Salt Lake City (Oral). Summa Cum Laude Award.
  6. Christen T., Ni W.W., Qiu D., Moseley M.E., Zaharchuk G. Imaging the Fragile Brain: Using BOLD Signal Fluctuations to Study Perfusion in Normal Subjects and Patients with Cerebrovascular Disease. ISMRM, Salt Lake City (Poster). Magna Cum Laude Award.
  7. Ni W.W., Christen T., Zaharchuk G. Myelin Water Fraction Measurement Using Free Induction Decay and Refocused Gradient Echoes. ISMRM, Salt Lake City (ePoster).
  8. Ni W.W., Christen T., Zun Z., Zaharchuk G. Does T2' Depend on the Measurement Method? Considerations for Quantitative BOLD Oxygenation. ISMRM, Salt Lake City (ePoster).
  9. Pannetier N., Lemasson B., Christen T., Zaharchuk G., Barbier E.L., Schuff N. Quantitative BOLD Analysis Using a Numerical Model. Blood Volume, Oxygenation and Vessel Size Measurement in the Rat Brain. ISMRM, Salt Lake City (ePoster). Magna Cum Laude Award.
  10. Pannetier N., Sohlin M., Christen T., Schad L.R., Schuff N. Numerical Approach for Quantitative BOLD with Vessel Size Estimate – Validation on Phantom. ISMRM, Salt Lake City (ePoster).
  11. Qiu D., Christen T., Park J.M., Moseley M.E., Zaharchuk G. Resting State fMRI Using Multi Echo EPI (ME-EPI): A Study of Echo Time Dependence of Sensitivity. ISMRM, Salt Lake City (Poster).
  12. Qiu D., Zaharchuk G., Christen T., Ni W.W., Glover G., Moseley M.E. Resting State Neural Network Demonstrated with Cerebral Blood Volume Based fMRI Using the USPIO Agent Ferumoxytol in Humans. ISMRM, Salt Lake City (Poster). Magna Cum Laude Award.
  13. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Echo Time Dependence of Resting Signal Fluctuations in USPIO Based Cerebral Blood Volume Imaging: Implications for Task-Based and Resting State fMRI. ISMRM, Salt Lake City (Poster).
  14. Qiu D., Christen T., Ni W.W., Scmiedeskamp H., Zaharchuk G., Moseley M.E. Simultaneous Spin Echo and Gradient Echo for fMRI Using the USPIO Agent Ferumoxytol in Humans: Enhanced Sensitivity and Potentials for High Resolution Mapping. ISMRM, Salt Lake City (Oral).
  15. Jahanian H., Ni W.W., Christen T., Tamura M.K., Moseley M.E., Zaharchuk G. Spontaneous BOLD Signal Fluctuations in the Young and Elderly Brain: a Non-Contrast Biomarker of Cerebral Vasomotor Reactivity? ISMRM, Salt Lake City (Poster).
  16. Christen T., Zhao C., Coram M.A., Straka M., Bammer R., Albers G.W., Zaharchuk G. An ASL Collateral Score Can Identify Improved Quantitative Cerebral Blood Flow in Acute Stroke Patients. Proc AHA International Stroke Conference, Honolulu, (Poster).
  17. Andre J.B., NagpalS., Hippe D.S., Schmiedeskamp H., Bammer R., Thomas R., Straka, M., Recht L., Zaharchuk G. Cerebral Blood Flow Changes in Glioblastoma Multiforme Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain. ISMRM, Salt Lake City (Poster)
  18. Holdsworth S.J., Skare S., Yeom K., Antonucci M.U., Andre J.B., Rosenberg J., Straka, M., Fischbein N.J., Zaharchuk G., Bammer R. Dual-Echo Diffusion-Weighted EPI for Better Sensitivity to Acute Stroke. ISMRM, Salt Lake City (Oral)

2012

  1. Zaharchuk G., Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Bammer R., Moseley M.E. Cerebrovascular and Functional Magnetic Resonance Imaging with the Blood Pool Agent Ferumoxytol: Initial Experiences in Normal Subjects. ASNR (Oral). Outstanding Presentation Awards.
  2. Christen T., Qiu D., Ni W.W., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. Steady-State and Dynamic Susceptibility Contrast Using USPIOs in Humans. ISMRM, Melbourne (Oral). Summa Cum Laude Award.
  3. Christen T., Qiu D., Ni W.W., Hankov G., Zun Z., Moseley M.E., Zaharchuk G. High-Resolution Quantitative Cerebral Blood Volume Imaging in Humans Using the Blood Pool USPIO Contrast Agent Ferumoxytol. ISMRM, Melbourne (Poster). Magna Cum Laude Award.
  4. Christen T., Hankov G., Schmiedeskamp H., Bammer R., Zaharchuk G. Vessel Size Index and Cerebral Blood Volume Maps Using Hypercapnic Contrast at 3T. ISMRM, Melbourne (Oral).
  5. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Enhanced fMRI Sensitivity Using CBV Based Contrast with the Blood Pool USPIO Agent Ferumoxytol in Humans. ISMRM, Melbourne (Oral). Magna Cum Laude Award.
  6. Schmiedeskamp H., Straka M., Christen T., Andre J.B., Naqpal S., Recht L., Thomas R.P., Moseley M.E., Zaharchuk G., Bammer R. Spin- And Gradient-Echo PWI with Correction for T1- And T2(*)-Related Contrast Agent Extravasation Effects. ISMRM, Melbourne (Poster).
  7. Qiu D., Christen T., Ni W.W., Zaharchuk G., Moseley M.E. Vasculature Visualisation Using Blood Pool USPIO Contrast Agent Ferumoxytol in Humans. ISMRM, Melbourne (Poster).
  8. Schmiedeskamp H., Straka M., Christen T., Zaharchuk G., Bammer R. Precision and Accuracy of R2 and R2* Estimation with Spin- And Gradient-Echo EPI. ISMRM, Melbourne (Poster).
  9. Ni W.W., Qiu D., Christen T., Schmiedeskamp H., Bammer R., Moseley M.E., Zaharchuk G. Cerebral MR Signal Changes Induced by Ferumoxytol and Saline Dilution Boluses: Initial Human Experience. ISMRM, Melbourne (Poster).
  10. Qiu D., Christen T., Ni W.W., Zaharchuk G., Moseley M.E. Characterization of Blood Pool Half Life of USPIO Contrast Agent Ferumoxytol in Humans. ISMRM, Melbourne (Poster).
  11. Hankov G., Christen T., Schmiedeskamp H., Bammer R., Zaharchuk G. Analysis of MR Signal Dynamics During Carbogen Inhalation Using a Combined Spin- And Gradient-Echo (SAGE) EPI Sequence. ISMRM, Melbourne (e-Poster).
  12. Zun Z., Hargreaves B., Zaharchuk G. Improved Multislice Cerebral Blood Flow Imaging Using Velocity-Selective Arterial Spin Labeling. ISMRM, Melbourne (Poster)
  13. Zun Z., Hargreaves B., Zaharchuk G. Near-Contiguous Spin Echo Imaging Using Matched-Phase RF and Its Application in Velocity-Selective Arterial Spin Labeling. ISMRM, Melbourne (Poster)
  14. Qiu D., Rex D.E., Saranathan M., Lober R.M., Zaharchuk G., Moseley M.E., Yeom K.W. Functional Blood Volume Imaging (FBVI) Using Blood Pool Gadolinium Contrast Agent Gadofosveset Trisodium. ISMRM, Melbourne (Poster)